277 related articles for article (PubMed ID: 31476292)
1. Brief exposure to full length parathyroid hormone-related protein (PTHrP) causes persistent generation of cyclic AMP through an endocytosis-dependent mechanism.
Ho PWM; Chan AS; Pavlos NJ; Sims NA; Martin TJ
Biochem Pharmacol; 2019 Nov; 169():113627. PubMed ID: 31476292
[TBL] [Abstract][Full Text] [Related]
2. PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway.
Martin TJ
Front Endocrinol (Lausanne); 2021; 12():833221. PubMed ID: 35126319
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.
Blind E; Raue F; Knappe V; Schroth J; Ziegler R
Exp Clin Endocrinol; 1993; 101(3):150-5. PubMed ID: 8223983
[TBL] [Abstract][Full Text] [Related]
4. Structurally diverse N-terminal peptides of parathyroid hormone (PTH) and PTH-related peptide (PTHRP) inhibit the Na+/H+ exchanger NHE3 isoform by binding to the PTH/PTHRP receptor type I and activating distinct signaling pathways.
Azarani A; Goltzman D; Orlowski J
J Biol Chem; 1996 Jun; 271(25):14931-6. PubMed ID: 8663042
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone (PTH) down-regulates PTH/PTH-related protein receptor gene expression in UMR-106 osteoblast-like cells via a 3',5'-cyclic adenosine monophosphate-dependent, protein kinase A-independent pathway.
Kawane T; Mimura J; Yanagawa T; Fujii-Kuriyama Y; Horiuchi N
J Endocrinol; 2003 Aug; 178(2):247-56. PubMed ID: 12904172
[TBL] [Abstract][Full Text] [Related]
6. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone and parathyroid hormone-related peptide activate the Na+/H+ exchanger NHE-1 isoform in osteoblastic cells (UMR-106) via a cAMP-dependent pathway.
Azarani A; Orlowski J; Goltzman D
J Biol Chem; 1995 Sep; 270(39):23166-72. PubMed ID: 7559463
[TBL] [Abstract][Full Text] [Related]
8. Mutation of phenylalanine-34 of parathyroid hormone disrupts NHERF1 regulation of PTH type I receptor signaling.
Wheeler D; Sneddon WB
Endocrine; 2006 Dec; 30(3):343-52. PubMed ID: 17526947
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
10. Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R.
Martin TJ; Sims NA; Seeman E
Endocr Rev; 2021 Jul; 42(4):383-406. PubMed ID: 33564837
[TBL] [Abstract][Full Text] [Related]
11. Sustained signalling by PTH modulates IP3 accumulation and IP3 receptors through cyclic AMP junctions.
Meena A; Tovey SC; Taylor CW
J Cell Sci; 2015 Jan; 128(2):408-20. PubMed ID: 25431134
[TBL] [Abstract][Full Text] [Related]
12. Biologic activities of parathyroid hormone (1-34) and parathyroid hormone-related peptide (1-34) in isolated perfused rat femur.
Lopez-Hilker S; Martin KJ; Sugimoto T; Slatopolsky E
J Lab Clin Med; 1992 Jun; 119(6):738-43. PubMed ID: 1317402
[TBL] [Abstract][Full Text] [Related]
13. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA
Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines.
Orloff JJ; Kats Y; Urena P; Schipani E; Vasavada RC; Philbrick WM; Behal A; Abou-Samra AB; Segre GV; Jüppner H
Endocrinology; 1995 Jul; 136(7):3016-23. PubMed ID: 7789327
[TBL] [Abstract][Full Text] [Related]
15. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
Koh AJ; Beecher CA; Rosol TJ; McCauley LK
Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells.
Fukayama S; Schipani E; Jüppner H; Lanske B; Kronenberg HM; Abou-Samra AB; Bringhurst FR
Endocrinology; 1994 Apr; 134(4):1851-8. PubMed ID: 8137752
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation.
van de Stolpe A; Karperien M; Löwik CW; Jüppner H; Segre GV; Abou-Samra AB; de Laat SW; Defize LH
J Cell Biol; 1993 Jan; 120(1):235-43. PubMed ID: 8380175
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts.
Jongen JW; Willemstein-van Hove EC; van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
J Bone Miner Res; 1996 Sep; 11(9):1218-25. PubMed ID: 8864895
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells.
Chen HL; Demiralp B; Schneider A; Koh AJ; Silve C; Wang CY; McCauley LK
J Biol Chem; 2002 May; 277(22):19374-81. PubMed ID: 11897779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
